The aerobic capacity in patients with antisynthetase syndrome and dermatomyositis (2019)
- Authors:
- Autor USP: SHINJO, SAMUEL KATSUYUKI - FM
- Unidade: FM
- DOI: 10.1186/s42358-019-0109-1
- Subjects: DERMATOPATIAS; MIOSITE; DOENÇAS CARDIOVASCULARES; FATORES DE RISCO; TESTE DE ESFORÇO; CAPACIDADE AERÓBICA; ESTUDOS TRANSVERSAIS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Advances in rheumatology
- ISSN: 2523-3106
- Volume/Número/Paginação/Ano: v. 60, n. 1, article ID 3, 9p, 2019
- Este artigo possui versão em acesso aberto
- URL de acesso aberto
- PDF de acesso aberto
- Versão do Documento: Versão publicada (Published version)
-
Status: Artigo publicado em periódico de acesso aberto (Gold Open Access) -
ABNT
SANTOS, Alexandre Moura dos et al. The aerobic capacity in patients with antisynthetase syndrome and dermatomyositis. Advances in rheumatology, v. 60, n. 1, 2019Tradução . . Disponível em: https://doi.org/10.1186/s42358-019-0109-1. Acesso em: 11 mar. 2026. -
APA
Santos, A. M. dos, Misse, R. G., Borges, I. B. P., & Shinjo, S. K. (2019). The aerobic capacity in patients with antisynthetase syndrome and dermatomyositis. Advances in rheumatology, 60( 1). doi:10.1186/s42358-019-0109-1 -
NLM
Santos AM dos, Misse RG, Borges IBP, Shinjo SK. The aerobic capacity in patients with antisynthetase syndrome and dermatomyositis [Internet]. Advances in rheumatology. 2019 ; 60( 1):[citado 2026 mar. 11 ] Available from: https://doi.org/10.1186/s42358-019-0109-1 -
Vancouver
Santos AM dos, Misse RG, Borges IBP, Shinjo SK. The aerobic capacity in patients with antisynthetase syndrome and dermatomyositis [Internet]. Advances in rheumatology. 2019 ; 60( 1):[citado 2026 mar. 11 ] Available from: https://doi.org/10.1186/s42358-019-0109-1 - High prevalence of necrotizing myofibers in adult dermatomyositis muscle biopsies
- Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us?
- Clinical manifestations, outcomes, and antibody profile of Brazilian adult patients with dermatomyositis: a single-center longitudinal study
- Long-term effects of early pulse methylprednisolone and intravenous immunoglobulin in patients with dermatomyositis and polymyositis
- Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys
- Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study
- Cardiovascular manifestations in idiopathic inflammatory myopathies
- Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study
- Vaccine hesitancy in patients with autoimmune diseases. [Carta]: data from the coronavirus disease-2019 vaccination in autoimmune diseases study
- Different clinical phenotypes in anti-melanoma differentiation-associated protein 5-associated positive dermatomyositis
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
